In 2009, a pioneer study demonstrated that tau extracted from tau(P301S) transgenic mice, which carries one of the frontotemporal dementia tau mutations and develops tau inclusions, and injected into healthy mice that do not normally develop tau inclusions, lead to development of tau pathology [112]. Here, MAPT is linked to frontotemporal dementia.